4.21
-0.11(-2.55%)
Currency In USD
| Previous Close | 4.32 |
| Open | 4.25 |
| Day High | 4.32 |
| Day Low | 4.15 |
| 52-Week High | 6.3 |
| 52-Week Low | 2.2 |
| Volume | 187,217 |
| Average Volume | 307,860 |
| Market Cap | 237.71M |
| PE | -2.34 |
| EPS | -1.8 |
| Moving Average 50 Days | 4.26 |
| Moving Average 200 Days | 3.3 |
| Change | -0.11 |
If you invested $1000 in Orchestra BioMed Holdings, Inc. (OBIO) since IPO date, it would be worth $369.3 as of December 30, 2025 at a share price of $4.21. Whereas If you bought $1000 worth of Orchestra BioMed Holdings, Inc. (OBIO) shares 3 years ago, it would be worth $421.84 as of December 30, 2025 at a share price of $4.21.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Orchestra BioMed Announces AVIM Therapy and Virtue SAB Program Presentations at ICI Meeting
GlobeNewswire Inc.
Dec 08, 2025 12:00 PM GMT
Joint presentation by Orchestra BioMed and Medtronic leadership to discuss ongoing strategic collaboration for development and commercialization of AVIM Therapy for treatment of uncontrolled hypertension in patients indicated for a pacemaker NEW HOPE
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.
Nov 26, 2025 9:05 PM GMT
NEW HOPE, Pa., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through strategic partnerships with market
Orchestra BioMed to Host Business Update Call on November 12, 2025
GlobeNewswire Inc.
Nov 03, 2025 1:00 PM GMT
NEW HOPE, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through strategic partnerships with market